Chinese Private Sector Conglomerate Funds One-Year Training in the US for Two Chinese Geriatricians Under the MMAAP Foundation’s Irma and Paul Milstein Program for Senior Health
NEW YORK, May 6, 2014 – Wanxiang Group Corporation, a Chinese multinational automotive components manufacturing company, has made a contribution to the Milstein Medical Asian American Partnership Foundation (MMAAP Foundation) to support two Fellowships in Geriatric Medicine. The fellowships, under the MMAAP Foundation’s Irma and Paul Milstein Program for Senior Health, will allow two Chinese geriatrician investigators to receive one-year training at leading US medical institutions in 2014. Wanxiang Group Corporation has also agreed to continue their support by funding two additional investigators in 2015.
Wanxiang Group Corporation was established in 1969, and its businesses operations, among others, include automotive parts manufacturing, agriculture, aquaculture, real estate development, and infrastructure development. Wanxiang’s expansive philanthropic network has provided aid in education, shelter, senior care and other categories for many from disadvantaged communities and those who have been affected by natural disasters in China. Wanxiang has received several national recognitions for its charitable work in China.
The MMAAP Foundation was established in 2011 with a strong endorsement from China’s former Ministry of Health (now the National Health and Family Planning Commission). Its mission is to improve world health by facilitating exchanges and long-term partnerships between leading medical institutions and talents from the US and China, as well as greater Asia. The Foundation currently offers funding opportunities for Chinese researchers in Geriatric Medicine, Dermatology and Hematology in the form of fellowships and research project awards. The MMAAP Foundation plans to support other disciplines of research and make funding available to investigators from other regions of Asia in the future.
For a complete listing of the MMAAP Foundation’s awards, please visit www.mmaapf.org.
“Nearly 15% of China’s population is at the age of 60 or above, a phenomenon that urgently calls for advances in our senior health care system,” said Guanqiu Lu, Chairman of Wanxiang Group Corporation. “The MMAAP Foundation has created a unique platform to provide exchange opportunities for Chinese geriatricians to connect with the international medical community. Wanxiang is privileged to help further advance this important mission which will create long-term benefits for not only China, but also for world health.”
“The MMAAP Foundation is committed to improving global health by encouraging exchanges and building partnerships between the US and China, as well as greater Asia,” said Howard P. Milstein, Chairman of the MMAAP Foundation. “Enhancing senior health care is a crucial task for China as well as the rest of the world. I am appreciative of Wanxiang Group Corporation’s foresight in supporting and recognizing our mission. Such a generous contribution will not only allow us to facilitate much needed medical progress in an international setting, but also build trust and collaboration that will benefit future generations.”
About the Milstein Medical Asian American Partnership Foundation
The mission of the Milstein Medical Asian American Partnership Foundation (MMAAP Foundation) is to improve world health by developing mutually beneficial partnerships between the US and China, as well as greater Asia. Working with some of the premier health organizations in the world, the MMAAP Foundation brings together and funds exchanges among the best research, medical talent, and institutions in the regions. This strategy is a high priority for the MMAAP Foundation’s founders, Howard P. Milstein and the Paul Milstein Family. The MMAAP Foundation is a 501(c)(3) non-profit organization.
For more than 50 years, the Milstein family has been actively involved in health-related and medical philanthropy. The MMAAP Foundation builds upon this distinguished history in five areas: Senior Healthcare, Skin Disease and Melanoma, Reproductive Biology, Blood Research, and Translational Medicine.
The MMAAP Foundation works in close collaboration with other medical organizations supported by the Milstein family, including American Skin Association, the Milstein Melanoma Research Program at the Rockefeller University, the Howard and Georgeanna Jones Foundation for Reproductive Medicine, New York Blood Center, and the Program for Translational Chemical Biology at New York-Presbyterian Hospital/Weill Cornell Medical Center. For more information, please visit MMAAP Foundation’s website at www.mmaapf.org.